BAND Bandwidth | $17.00
-2.6% | 2/21/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Bandwidth (NASDAQ:BAND) on 2/21/2025 |
FIVN Five9 | $42.09
+1.0% | 2/21/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Five9 (NASDAQ:FIVN) on 2/21/2025 |
SPRY ARS Pharmaceuticals | $11.24
-4.6% | 2/21/2025 | Reiterated by | William Blair | Analyst L. Hanbury-Brown | Outperform | | Low | View details for William Blair rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 2/21/2025 |
DVAX Dynavax Technologies | $13.33
| 2/21/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Dynavax Technologies (NASDAQ:DVAX) on 2/21/2025 |
VERV Verve Therapeutics | $7.28
-7.0% | 2/21/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Verve Therapeutics (NASDAQ:VERV) on 2/21/2025 |
LDOS Leidos | $126.66
-2.6% | 2/21/2025 | Downgraded by | William Blair | Analyst Louie DiPalma | Outperform -> Market Perform | | High | View details for William Blair rating of Leidos (NYSE:LDOS) on 2/21/2025 |
GD General Dynamics | $243.02
-1.3% | 2/21/2025 | Downgraded by | William Blair | Analyst Louie DiPalma | Outperform -> Market Perform | | Low | View details for William Blair rating of General Dynamics (NYSE:GD) on 2/21/2025 |
CACI CACI International | $326.55
-4.4% | 2/21/2025 | Downgraded by | William Blair | Analyst Louie DiPalma | Outperform -> Market Perform | | High | View details for William Blair rating of CACI International (NYSE:CACI) on 2/21/2025 |
BAH Booz Allen Hamilton | $112.27
-1.2% | 2/21/2025 | Downgraded by | William Blair | Analyst Louie DiPalma | Outperform -> Market Perform | | Medium | View details for William Blair rating of Booz Allen Hamilton (NYSE:BAH) on 2/21/2025 |
KVYO Klaviyo | $41.79
-5.6% | 2/20/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Klaviyo (NYSE:KVYO) on 2/20/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
CVNA Carvana | $223.14
-9.9% | 2/20/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Carvana (NYSE:CVNA) on 2/20/2025 |
CAKE Cheesecake Factory | $54.65
-0.6% | 2/20/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Cheesecake Factory (NASDAQ:CAKE) on 2/20/2025 |
RELY Remitly Global | $23.86
-7.5% | 2/20/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Remitly Global (NASDAQ:RELY) on 2/20/2025 |
EXAS Exact Sciences | $49.26
-0.5% | 2/20/2025 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of Exact Sciences (NASDAQ:EXAS) on 2/20/2025 |
CSGP CoStar Group | $76.79
-2.0% | 2/19/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of CoStar Group (NASDAQ:CSGP) on 2/19/2025 |
FIS Fidelity National Information Services | $69.95
+0.1% | 2/18/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Fidelity National Information Services (NYSE:FIS) on 2/18/2025 |
JKHY Jack Henry & Associates | $171.13
+1.4% | 2/18/2025 | Reiterated by | William Blair | Analyst C. Kennedy | Outperform | | Medium | View details for William Blair rating of Jack Henry & Associates (NASDAQ:JKHY) on 2/18/2025 |
AXSM Axsome Therapeutics | $137.75
+6.7% | 2/18/2025 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of Axsome Therapeutics (NASDAQ:AXSM) on 2/18/2025 |
PSN Parsons | $59.45
-4.0% | 2/18/2025 | Upgraded by | William Blair | Analyst L. Dipalma | Market Perform -> Outperform | | High | View details for William Blair rating of Parsons (NYSE:PSN) on 2/18/2025 |
TWLO Twilio | $114.16
-3.3% | 2/14/2025 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of Twilio (NYSE:TWLO) on 2/14/2025 |
CWST Casella Waste Systems | $113.99
-1.5% | 2/14/2025 | Reiterated by | William Blair | Analyst T. Romeo | Outperform | | High | View details for William Blair rating of Casella Waste Systems (NASDAQ:CWST) on 2/14/2025 |
MCO Moody's | $499.62
-2.3% | 2/14/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Moody’s (NYSE:MCO) on 2/14/2025 |
RSG Republic Services | $230.73
-0.1% | 2/14/2025 | Reiterated by | William Blair | Analyst T. Romeo | Outperform | | Medium | View details for William Blair rating of Republic Services (NYSE:RSG) on 2/14/2025 |
TRU TransUnion | $91.75
-2.9% | 2/14/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of TransUnion (NYSE:TRU) on 2/14/2025 |
HUBS HubSpot | $726.43
-2.9% | 2/13/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of HubSpot (NYSE:HUBS) on 2/13/2025 |
MANH Manhattan Associates | $182.51
-1.9% | 2/13/2025 | Upgraded by | William Blair | Analyst Dylan Becker | Market Perform -> Outperform | | Low | View details for William Blair rating of Manhattan Associates (NASDAQ:MANH) on 2/13/2025 |
TEM Tempus AI | $68.09
-11.2% | 2/12/2025 | Downgraded by | William Blair | Analyst Andrew Brackmann | Outperform -> Market Perform | | High | View details for William Blair rating of Tempus AI (NASDAQ:TEM) on 2/12/2025 |
STAA STAAR Surgical | $16.87
+0.1% | 2/12/2025 | Downgraded by | William Blair | Analyst Margaret Kaczor | Outperform -> Market Perform | | High | View details for William Blair rating of STAAR Surgical (NASDAQ:STAA) on 2/12/2025 |
ACLS Axcelis Technologies | $63.11
-2.1% | 2/12/2025 | Downgraded by | William Blair | Analyst Jed Dorsheimer | Outperform -> Market Perform | | Low | View details for William Blair rating of Axcelis Technologies (NASDAQ:ACLS) on 2/12/2025 |
VSAT Viasat | $9.00
-3.9% | 2/7/2025 | Reiterated by | William Blair | - | Market Perform | | High | View details for William Blair rating of Viasat (NASDAQ:VSAT) on 2/7/2025 |
EHC Encompass Health | $97.42
-2.5% | 2/7/2025 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of Encompass Health (NYSE:EHC) on 2/7/2025 |
NBIX Neurocrine Biosciences | $120.69
+3.9% | 2/7/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Neurocrine Biosciences (NASDAQ:NBIX) on 2/7/2025 |
EFX Equifax | $238.04
-1.3% | 2/7/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Equifax (NYSE:EFX) on 2/7/2025 |
RBRK Rubrik | $69.67
-3.5% | 2/7/2025 | Initiated by | William Blair | Analyst Jason Ader | Market Perform | | Medium | View details for William Blair rating of Rubrik (NYSE:RBRK) on 2/7/2025 |
CXM Sprinklr | $8.90
-2.4% | 2/7/2025 | Downgraded by | William Blair | Analyst A. Bhatia | Outperform -> Market Perform | | Low | View details for William Blair rating of Sprinklr (NYSE:CXM) on 2/7/2025 |
WEX WEX | $150.48
-1.6% | 2/6/2025 | Reiterated by | William Blair | Analyst Andrew Jeffrey | Outperform -> Market Perform | | Low | View details for William Blair rating of WEX (NYSE:WEX) on 2/6/2025 |
HOLX Hologic | $64.47
+0.2% | 2/6/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Hologic (NASDAQ:HOLX) on 2/6/2025 |
MRSN Mersana Therapeutics | $0.53
+1.0% | 2/6/2025 | Initiated by | William Blair | Analyst Andy Hsieh | Outperform | | High | View details for William Blair rating of Mersana Therapeutics (NASDAQ:MRSN) on 2/6/2025 |
MRVL Marvell Technology | $103.85
-4.5% | 2/5/2025 | Upgraded by | William Blair | Analyst S. Naji | Strong-Buy | | Low | View details for William Blair rating of Marvell Technology (NASDAQ:MRVL) on 2/5/2025 |
MA Mastercard | $557.44
-1.0% | 1/31/2025 | Reiterated by | William Blair | Analyst A. Jeffrey | Outperform | | High | View details for William Blair rating of Mastercard (NYSE:MA) on 1/31/2025 |
Why Buffett and 100 members of Congress are Piling into this One Investment (Ad) This isn't just another investment.
It might be the last retirement stock you'll ever need.
But this window of opportunity is closing fast. Click here for the ticker >>> |
V Visa | $348.27
-0.6% | 1/31/2025 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of Visa (NYSE:V) on 1/31/2025 |
WM Waste Management | $227.89
-0.5% | 1/31/2025 | Reiterated by | William Blair | Analyst T. Romeo | Outperform | | Medium | View details for William Blair rating of Waste Management (NYSE:WM) on 1/31/2025 |
VRTX Vertex Pharmaceuticals | $484.24
+0.8% | 1/31/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 1/31/2025 |
APPF AppFolio | $211.66
-2.1% | 1/31/2025 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of AppFolio (NASDAQ:APPF) on 1/31/2025 |
TEAM Atlassian | $285.99
-4.2% | 1/31/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Atlassian (NASDAQ:TEAM) on 1/31/2025 |
CRGX CARGO Therapeutics | $3.77
+2.2% | 1/30/2025 | Downgraded by | William Blair | Analyst S. Corwin | Outperform -> Market Perform | | N/A | View details for William Blair rating of CARGO Therapeutics (NASDAQ:CRGX) on 1/30/2025 |
CVLT Commvault Systems | $170.61
-7.7% | 1/30/2025 | Upgraded by | William Blair | Analyst Jason Ader | Market Perform -> Outperform | | High | View details for William Blair rating of Commvault Systems (NASDAQ:CVLT) on 1/30/2025 |
FNA Paragon 28 | $13.02
-0.3% | 1/29/2025 | Downgraded by | William Blair | Analyst Brandon Vazquez | Outperform -> Market Perform | | High | View details for William Blair rating of Paragon 28 (NYSE:FNA) on 1/29/2025 |
AXP American Express | $295.23
-2.8% | 1/27/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of American Express (NYSE:AXP) on 1/27/2025 |
SAUHY Straumann | $14.42
-1.6% | 1/24/2025 | Upgraded by | William Blair | Analyst B. Vazquez | Strong-Buy | | Medium | View details for William Blair rating of Straumann (OTCMKTS:SAUHY) on 1/24/2025 |
TWLO Twilio | $114.16
-3.3% | 1/24/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Twilio (NYSE:TWLO) on 1/24/2025 |
AXSM Axsome Therapeutics | $137.75
+6.7% | 1/24/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Axsome Therapeutics (NASDAQ:AXSM) on 1/24/2025 |
SOFI SoFi Technologies | $14.67
-5.7% | 1/24/2025 | Reiterated by | William Blair | Analyst A. Jeffrey | Outperform | | Low | View details for William Blair rating of SoFi Technologies (NASDAQ:SOFI) on 1/24/2025 |
GEV GE Vernova | $327.68
-8.9% | 1/23/2025 | Reiterated by | William Blair | Analyst J. Dorsheimer | Outperform | | High | View details for William Blair rating of GE Vernova (NYSE:GEV) on 1/23/2025 |
PSN Parsons | $59.45
-4.0% | 1/23/2025 | Downgraded by | William Blair | Analyst Louie DiPalma | Outperform -> Market Perform | | High | View details for William Blair rating of Parsons (NYSE:PSN) on 1/23/2025 |
CRL Charles River Laboratories International | $163.11
+0.5% | 1/22/2025 | Downgraded by | William Blair | Analyst Max Smock | Outperform -> Market Perform | | Low | View details for William Blair rating of Charles River Laboratories International (NYSE:CRL) on 1/22/2025 |
STRL Sterling Infrastructure | $116.29
-6.4% | 1/17/2025 | Initiated by | William Blair | Analyst Louie DiPalma | Outperform | | High | View details for William Blair rating of Sterling Infrastructure (NASDAQ:STRL) on 1/17/2025 |
DNLI Denali Therapeutics | $20.75
-3.9% | 1/15/2025 | Reiterated by | William Blair | Analyst S. Schram | Outperform | | High | View details for William Blair rating of Denali Therapeutics (NASDAQ:DNLI) on 1/15/2025 |
NMRA Neumora Therapeutics | $1.80
+5.3% | 1/15/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Neumora Therapeutics (NASDAQ:NMRA) on 1/15/2025 |
AFRM Affirm | $68.55
-8.1% | 1/15/2025 | Initiated by | William Blair | Analyst Andrew Jeffrey | Outperform | | High | View details for William Blair rating of Affirm (NASDAQ:AFRM) on 1/15/2025 |
SOFI SoFi Technologies | $14.67
-5.7% | 1/15/2025 | Initiated by | William Blair | Analyst Andrew Jeffrey | Outperform | | High | View details for William Blair rating of SoFi Technologies (NASDAQ:SOFI) on 1/15/2025 |
CRL Charles River Laboratories International | $163.11
+0.5% | 1/14/2025 | Reiterated by | William Blair | Analyst Max Smock | Outperform -> Outperform | | Low | View details for William Blair rating of Charles River Laboratories International (NYSE:CRL) on 1/14/2025 |
ICLR ICON Public | $201.39
-0.2% | 1/14/2025 | Reiterated by | William Blair | Analyst Max Smock | Outperform -> Outperform | | High | View details for William Blair rating of ICON Public (NASDAQ:ICLR) on 1/14/2025 |
CVRX CVRx | $13.85
-1.1% | 1/14/2025 | Upgraded by | William Blair | Analyst Margaret Kaczor | Market Perform -> Outperform | | High | View details for William Blair rating of CVRx (NASDAQ:CVRX) on 1/14/2025 |
BIIB Biogen | $140.64
+2.6% | 1/13/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Biogen (NASDAQ:BIIB) on 1/13/2025 |
EXAS Exact Sciences | $49.26
-0.5% | 1/13/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Exact Sciences (NASDAQ:EXAS) on 1/13/2025 |
HOLX Hologic | $64.47
+0.2% | 1/13/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Hologic (NASDAQ:HOLX) on 1/13/2025 |
VRTX Vertex Pharmaceuticals | $484.24
+0.8% | 1/13/2025 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 1/13/2025 |
ENFN Enfusion | $11.50
+1.3% | 1/13/2025 | Reiterated by | William Blair | Analyst Bhavan Suri | Outperform -> Market Perform | | High | View details for William Blair rating of Enfusion (NYSE:ENFN) on 1/13/2025 |
JANX Janux Therapeutics | $36.01
-3.1% | 1/10/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Janux Therapeutics (NASDAQ:JANX) on 1/10/2025 |
ACCD Accolade | $6.93
+0.3% | 1/8/2025 | Downgraded by | William Blair | Analyst R. Daniels | Strong-Buy -> Hold | | Low | View details for William Blair rating of Accolade (NASDAQ:ACCD) on 1/8/2025 |
CBOE Cboe Global Markets | $210.93
+1.0% | 1/9/2025 | Initiated by | William Blair | Analyst J. Schmitt | Market Perform | | Low | View details for William Blair rating of Cboe Global Markets (NASDAQ:CBOE) on 1/9/2025 |
KRUS Kura Sushi USA | $69.85
-5.7% | 1/8/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Kura Sushi USA (NASDAQ:KRUS) on 1/8/2025 |
SLP Simulations Plus | $31.77
-0.2% | 1/8/2025 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Simulations Plus (NASDAQ:SLP) on 1/8/2025 |
NARI Inari Medical | $79.97
+0.1% | 1/7/2025 | Reiterated by | William Blair | Analyst M. Kaczor | Outperform -> Market Perform | | Low | View details for William Blair rating of Inari Medical (NASDAQ:NARI) on 1/7/2025 |
CSGP CoStar Group | $76.79
-2.0% | 1/6/2025 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of CoStar Group (NASDAQ:CSGP) on 1/6/2025 |
TTAN ServiceTitan | $96.76
-0.8% | 1/6/2025 | Initiated by | William Blair | Analyst D. Becker | Outperform | | N/A | View details for William Blair rating of ServiceTitan (NASDAQ:TTAN) on 1/6/2025 |
DNLI Denali Therapeutics | $20.75
-3.9% | 1/3/2025 | Initiated by | William Blair | Analyst S. Schram | Outperform | | N/A | View details for William Blair rating of Denali Therapeutics (NASDAQ:DNLI) on 1/3/2025 |
ELEV Elevation Oncology | $0.61
-6.5% | 1/3/2025 | Initiated by | William Blair | Analyst A. Hsieh | Outperform | | N/A | View details for William Blair rating of Elevation Oncology (NASDAQ:ELEV) on 1/3/2025 |
AYI Acuity Brands | $309.11
-3.8% | 1/2/2025 | Upgraded by | William Blair | Analyst R. Merkel | Market Perform -> Outperform | | N/A | View details for William Blair rating of Acuity Brands (NYSE:AYI) on 1/2/2025 |
KRT Karat Packaging | $30.99
-2.8% | 1/2/2025 | Downgraded by | William Blair | Analyst R. Merkel | Outperform -> Market Perform | | N/A | View details for William Blair rating of Karat Packaging (NASDAQ:KRT) on 1/2/2025 |
HLMN Hillman Solutions | $10.02
-1.0% | 1/2/2025 | Downgraded by | William Blair | Analyst R. Merkel | Outperform -> Market Perform | | N/A | View details for William Blair rating of Hillman Solutions (NASDAQ:HLMN) on 1/2/2025 |
APLT Applied Therapeutics | $0.53
-6.2% | 12/23/2024 | Downgraded by | William Blair | Analyst S. Corwin | Outperform -> Market Perform | | N/A | View details for William Blair rating of Applied Therapeutics (NASDAQ:APLT) on 12/23/2024 |
IONS Ionis Pharmaceuticals | $32.33
-1.1% | 12/20/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 12/20/2024 |
ZETA Zeta Global | $20.71
-7.7% | 12/19/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Zeta Global (NYSE:ZETA) on 12/19/2024 |
SMWB Similarweb | $9.59
-3.2% | 12/19/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Similarweb (NYSE:SMWB) on 12/19/2024 |
KVYO Klaviyo | $41.79
-5.6% | 12/19/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Klaviyo (NYSE:KVYO) on 12/19/2024 |
BRZE Braze | $39.55
-2.7% | 12/19/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Braze (NASDAQ:BRZE) on 12/19/2024 |
MNDY monday.com | $300.65
-2.4% | 12/18/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of monday.com (NASDAQ:MNDY) on 12/18/2024 |
PLTR Palantir Technologies | $101.33
-4.6% | 12/18/2024 | Reiterated by | William Blair | - | Underperform | | N/A | View details for William Blair rating of Palantir Technologies (NASDAQ:PLTR) on 12/18/2024 |
Nvidia’s Next Big Move Comes on Feb. 26 (Ad) Nvidia isn't the only company that benefits greatly from these earnings calls.
That's because a handful of companies partnering with Nvidia on its latest AI Superproject …
Companies we refer to as Nvidia's "Silent Partners" …
And they could benefit greatly as well on Feb. 26. Click here to find out who they are. |
EVTC EVERTEC | $33.15
-0.7% | 12/18/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of EVERTEC (NYSE:EVTC) on 12/18/2024 |
BROS Dutch Bros | $76.09
-7.2% | 12/17/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Dutch Bros (NYSE:BROS) on 12/17/2024 |
NBIX Neurocrine Biosciences | $120.69
+3.9% | 12/16/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Neurocrine Biosciences (NASDAQ:NBIX) on 12/16/2024 |
INCY Incyte | $72.05
+0.9% | 12/13/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Incyte (NASDAQ:INCY) on 12/13/2024 |
KROS Keros Therapeutics | $11.01
-0.2% | 12/12/2024 | Downgraded by | William Blair | Analyst M. Phipps | Outperform -> Market Perform | | N/A | View details for William Blair rating of Keros Therapeutics (NASDAQ:KROS) on 12/12/2024 |
GEV GE Vernova | $327.68
-8.9% | 12/11/2024 | Reiterated by | William Blair | Analyst J. Dorsheimer | Outperform | | N/A | View details for William Blair rating of GE Vernova (NYSE:GEV) on 12/11/2024 |
FA First Advantage | $18.24
-2.7% | 12/11/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of First Advantage (NYSE:FA) on 12/11/2024 |
IQV IQVIA | $190.94
-1.6% | 12/11/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of IQVIA (NYSE:IQV) on 12/11/2024 |
PLAY Dave & Buster's Entertainment | $23.64
-2.0% | 12/11/2024 | Reiterated by | William Blair | Analyst S. Zackfia | Outperform -> Market Perform | | N/A | View details for William Blair rating of Dave & Buster’s Entertainment (NASDAQ:PLAY) on 12/11/2024 |
LULU Lululemon Athletica | $358.97
-1.9% | 12/6/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Lululemon Athletica (NASDAQ:LULU) on 12/6/2024 |
SPNS Sapiens International | $27.95
-2.8% | 12/6/2024 | Reiterated by | William Blair | - | Market Perform | | N/A | View details for William Blair rating of Sapiens International (NASDAQ:SPNS) on 12/6/2024 |
CCRN Cross Country Healthcare | $18.10
+0.3% | 12/4/2024 | Downgraded by | William Blair | Analyst T. Romeo | Strong-Buy -> Hold | | N/A | View details for William Blair rating of Cross Country Healthcare (NASDAQ:CCRN) on 12/4/2024 |
NCNO nCino | $32.06
-2.4% | 12/5/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of nCino (NASDAQ:NCNO) on 12/5/2024 |
AVAV AeroVironment | $154.79
-2.1% | 12/5/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of AeroVironment (NASDAQ:AVAV) on 12/5/2024 |
SYM Symbotic | $24.47
-6.2% | 12/5/2024 | Reiterated by | William Blair | - | Market Perform | | N/A | View details for William Blair rating of Symbotic (NASDAQ:SYM) on 12/5/2024 |
APG APi Group | $39.86
-2.5% | 12/5/2024 | Reiterated by | William Blair | Analyst T. Mulrooney | Outperform | | N/A | View details for William Blair rating of APi Group (NYSE:APG) on 12/5/2024 |
PLTR Palantir Technologies | $101.33
-4.6% | 12/4/2024 | Reiterated by | William Blair | - | Underperform | | N/A | View details for William Blair rating of Palantir Technologies (NASDAQ:PLTR) on 12/4/2024 |
VIGL Vigil Neuroscience | $3.03
+4.8% | 12/4/2024 | Initiated by | William Blair | Analyst S. Schram | Outperform | | N/A | View details for William Blair rating of Vigil Neuroscience (NASDAQ:VIGL) on 12/4/2024 |
JANX Janux Therapeutics | $36.01
-3.1% | 12/3/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Janux Therapeutics (NASDAQ:JANX) on 12/3/2024 |
APLT Applied Therapeutics | $0.53
-6.2% | 11/28/2024 | Upgraded by | William Blair | Analyst S. Corwin | Strong-Buy | | N/A | View details for William Blair rating of Applied Therapeutics (NASDAQ:APLT) on 11/28/2024 |
FIVE Five Below | $85.92
-3.6% | 12/2/2024 | Reiterated by | William Blair | Analyst P. Blee | Market Perform | | N/A | View details for William Blair rating of Five Below (NASDAQ:FIVE) on 12/2/2024 |
PNST Pinstripes | $0.32
+1.6% | 11/27/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Pinstripes (NYSE:PNST) on 11/27/2024 |
LESL Leslie's | $1.42
-4.1% | 11/26/2024 | Reiterated by | William Blair | - | Market Perform | | N/A | View details for William Blair rating of Leslie’s (NASDAQ:LESL) on 11/26/2024 |
RBC RBC Bearings | $357.37
-3.1% | 11/26/2024 | Reiterated by | William Blair | Analyst R. Sparenblek | Outperform | | N/A | View details for William Blair rating of RBC Bearings (NYSE:RBC) on 11/26/2024 |
CRGX CARGO Therapeutics | $3.77
+2.2% | 11/26/2024 | Initiated by | William Blair | Analyst S. Corwin | Outperform | | N/A | View details for William Blair rating of CARGO Therapeutics (NASDAQ:CRGX) on 11/26/2024 |
MA Mastercard | $557.44
-1.0% | 11/25/2024 | Reiterated by | William Blair | Analyst A. Jeffrey | Outperform | | N/A | View details for William Blair rating of Mastercard (NYSE:MA) on 11/25/2024 |
NDAQ Nasdaq | $81.07
-1.8% | 11/25/2024 | Initiated by | William Blair | Analyst J. Schmitt | Outperform | | N/A | View details for William Blair rating of Nasdaq (NASDAQ:NDAQ) on 11/25/2024 |
TLX Telix Pharmaceuticals Limited American Depositary Shares | $19.50
+12.0% | 11/19/2024 | Upgraded by | William Blair | Analyst A. Hsieh | Strong-Buy | | N/A | View details for William Blair rating of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) on 11/19/2024 |
EXAS Exact Sciences | $49.26
-0.5% | 11/21/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Exact Sciences (NASDAQ:EXAS) on 11/21/2024 |
ULTA Ulta Beauty | $361.54
-1.4% | 11/21/2024 | Downgraded by | William Blair | Analyst D. Carden | Outperform -> Market Perform | | N/A | View details for William Blair rating of Ulta Beauty (NASDAQ:ULTA) on 11/21/2024 |
PYXS Pyxis Oncology | $1.28
-5.9% | 11/21/2024 | Downgraded by | William Blair | Analyst A. Hsieh | Outperform -> Market Perform | | N/A | View details for William Blair rating of Pyxis Oncology (NASDAQ:PYXS) on 11/21/2024 |
AIOT Powerfleet | $7.43
-3.4% | 11/21/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Powerfleet (NASDAQ:AIOT) on 11/21/2024 |
QDEL QuidelOrtho | $40.46
-1.4% | 11/20/2024 | Reiterated by | William Blair | - | Market Perform | | N/A | View details for William Blair rating of QuidelOrtho (NASDAQ:QDEL) on 11/20/2024 |
VKTX Viking Therapeutics | $34.07
+7.7% | 11/20/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Viking Therapeutics (NASDAQ:VKTX) on 11/20/2024 |
SLN Silence Therapeutics | $4.79
-4.2% | 11/19/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Silence Therapeutics (NASDAQ:SLN) on 11/19/2024 |
NGNE Neurogene | $17.36
+0.3% | 11/19/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Neurogene (NASDAQ:NGNE) on 11/19/2024 |
LRMR Larimar Therapeutics | $3.19
-2.4% | 11/19/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Larimar Therapeutics (NASDAQ:LRMR) on 11/19/2024 |
ALNY Alnylam Pharmaceuticals | $250.59
-0.2% | 11/19/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 11/19/2024 |
CABA Cabaletta Bio | $2.05
-2.2% | 11/18/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Cabaletta Bio (NASDAQ:CABA) on 11/18/2024 |
NTLA Intellia Therapeutics | $12.17
-0.7% | 11/18/2024 | Reiterated by | William Blair | - | Neutral | $14.00 | N/A | View details for William Blair rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/18/2024 |
INGM Ingram Micro | $23.29
-1.6% | 11/18/2024 | Initiated by | William Blair | Analyst M. Nolan | Outperform | | N/A | View details for William Blair rating of Ingram Micro (NYSE:INGM) on 11/18/2024 |
XYZ Block | $68.34
-17.7% | 11/15/2024 | Reiterated by | William Blair | Analyst A. Jeffrey | Outperform | | N/A | View details for William Blair rating of Block (NYSE:XYZ) on 11/15/2024 |
REKR Rekor Systems | $1.70
-7.6% | 11/15/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Rekor Systems (NASDAQ:REKR) on 11/15/2024 |
BV BrightView | $13.47
-1.6% | 11/15/2024 | Upgraded by | William Blair | Analyst T. Mulrooney | Market Perform -> Outperform | | N/A | View details for William Blair rating of BrightView (NYSE:BV) on 11/15/2024 |
ALLO Allogene Therapeutics | $2.17
-4.0% | 11/14/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Allogene Therapeutics (NASDAQ:ALLO) on 11/14/2024 |
JANX Janux Therapeutics | $36.01
-3.1% | 11/14/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Janux Therapeutics (NASDAQ:JANX) on 11/14/2024 |
OPRX OptimizeRx | $5.78
-6.6% | 11/14/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of OptimizeRx (NASDAQ:OPRX) on 11/14/2024 |
BOX BOX | $33.48
-3.5% | 11/14/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of BOX (NYSE:BOX) on 11/14/2024 |
PSTG Pure Storage | $65.14
-3.9% | 11/14/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Pure Storage (NYSE:PSTG) on 11/14/2024 |
XGN Exagen | $3.58
-5.3% | 11/13/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Exagen (NASDAQ:XGN) on 11/13/2024 |
Nvidia’s Next Big Move Comes on Feb. 26 (Ad) Nvidia isn't the only company that benefits greatly from these earnings calls.
That's because a handful of companies partnering with Nvidia on its latest AI Superproject …
Companies we refer to as Nvidia's "Silent Partners" …
And they could benefit greatly as well on Feb. 26. Click here to find out who they are. |
FGEN FibroGen | $0.71
-8.6% | 11/13/2024 | Reiterated by | William Blair | - | Market Perform | | N/A | View details for William Blair rating of FibroGen (NASDAQ:FGEN) on 11/13/2024 |
KZR Kezar Life Sciences | $6.05
-5.5% | 11/13/2024 | Reiterated by | William Blair | - | Market Perform | | N/A | View details for William Blair rating of Kezar Life Sciences (NASDAQ:KZR) on 11/13/2024 |
KRRO Korro Bio | $26.29
-8.2% | 11/13/2024 | Reiterated by | William Blair | Analyst M. Minter | Outperform | | N/A | View details for William Blair rating of Korro Bio (NASDAQ:KRRO) on 11/13/2024 |
TPST Tempest Therapeutics | $0.86
-5.1% | 11/13/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Tempest Therapeutics (NASDAQ:TPST) on 11/13/2024 |
FA First Advantage | $18.24
-2.7% | 11/13/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of First Advantage (NYSE:FA) on 11/13/2024 |
CAVA CAVA Group | $108.05
-8.9% | 11/13/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of CAVA Group (NYSE:CAVA) on 11/13/2024 |
AMGN Amgen | $303.01
+1.7% | 11/12/2024 | Reiterated by | William Blair | - | Outperform | | N/A | View details for William Blair rating of Amgen (NASDAQ:AMGN) on 11/12/2024 |
FTRE Fortrea | $14.88
-4.7% | 11/8/2024 | Reiterated by | William Blair | - | Market Perform | | N/A | View details for William Blair rating of Fortrea (NASDAQ:FTRE) on 11/8/2024 |
MRVI Maravai LifeSciences | $4.11
+4.1% | 11/8/2024 | Reiterated by | William Blair | Analyst M. Larew | Outperform -> Market Perform | | N/A | View details for William Blair rating of Maravai LifeSciences (NASDAQ:MRVI) on 11/8/2024 |
AMN AMN Healthcare Services | $27.50
+6.4% | 11/8/2024 | Downgraded by | William Blair | Analyst T. Romeo | Outperform -> Market Perform | | N/A | View details for William Blair rating of AMN Healthcare Services (NYSE:AMN) on 11/8/2024 |
AGL agilon health | $3.53
-2.6% | 11/8/2024 | Downgraded by | William Blair | Analyst R. Daniels | Outperform -> Market Perform | | N/A | View details for William Blair rating of agilon health (NYSE:AGL) on 11/8/2024 |
JKHY Jack Henry & Associates | $171.13
+1.4% | 11/6/2024 | Downgraded by | William Blair | Analyst C. Kennedy | Strong-Buy -> Hold | | N/A | View details for William Blair rating of Jack Henry & Associates (NASDAQ:JKHY) on 11/6/2024 |
WRBY Warby Parker | $24.03
-5.0% | 11/7/2024 | Upgraded by | William Blair | Analyst D. Carden | Market Perform -> Outperform | | N/A | View details for William Blair rating of Warby Parker (NYSE:WRBY) on 11/7/2024 |
CDMO Avid Bioservices | $12.50
+0.1% | 11/7/2024 | Reiterated by | William Blair | - | Market Perform | | N/A | View details for William Blair rating of Avid Bioservices (NASDAQ:CDMO) on 11/7/2024 |
CLVT Clarivate | $4.85
+0.1% | 11/6/2024 | Downgraded by | William Blair | Analyst A. Nicholas | Outperform -> Market Perform | | N/A | View details for William Blair rating of Clarivate (NYSE:CLVT) on 11/6/2024 |
SLP Simulations Plus | $31.77
-0.2% | 11/6/2024 | Reiterated by | William Blair | Analyst M. Smock | Outperform | | N/A | View details for William Blair rating of Simulations Plus (NASDAQ:SLP) on 11/6/2024 |
UPB Upstream Bio | $7.98
-3.0% | 11/5/2024 | Initiated by | William Blair | Analyst M. Phipps | Outperform | | High | View details for William Blair rating of Upstream Bio (NASDAQ:UPB) on 11/5/2024 |
CBLL CeriBell | $24.69
+6.8% | 11/5/2024 | Initiated by | William Blair | Analyst M. Kaczor | Outperform | | High | View details for William Blair rating of CeriBell (NASDAQ:CBLL) on 11/5/2024 |
MQ Marqeta | $3.69
-5.9% | 11/5/2024 | Downgraded by | William Blair | Analyst C. Kennedy | Outperform -> Market Perform | | High | View details for William Blair rating of Marqeta (NASDAQ:MQ) on 11/5/2024 |
ARGX argenx | $644.48
-0.5% | 11/1/2024 | Upgraded by | William Blair | Analyst M. Minter | Market Perform -> Outperform | | Medium | View details for William Blair rating of argenx (NASDAQ:ARGX) on 11/1/2024 |
ALTR Altair Engineering | $111.78
| 10/31/2024 | Reiterated by | William Blair | Analyst D. Becker | Outperform -> Market Perform | | High | View details for William Blair rating of Altair Engineering (NASDAQ:ALTR) on 10/31/2024 |
BMRN BioMarin Pharmaceutical | $68.25
-0.7% | 10/30/2024 | Downgraded by | William Blair | Analyst S. Corwin | Outperform -> Market Perform | | High | View details for William Blair rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 10/30/2024 |
PRM Cott | C$13.00
+0.9% | 10/24/2024 | Upgraded by | William Blair | Analyst J. Andersen | Strong-Buy | | N/A | View details for William Blair rating of Cott (TSE:PRM) on 10/24/2024 |
SLP Simulations Plus | $31.77
-0.2% | 10/24/2024 | Reiterated by | William Blair | Analyst M. Smock | Outperform | | High | View details for William Blair rating of Simulations Plus (NASDAQ:SLP) on 10/24/2024 |
MEDP Medpace | $340.78
-1.2% | 10/22/2024 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Medpace (NASDAQ:MEDP) on 10/22/2024 |
BWIN The Baldwin Insurance Group | $39.18
-2.7% | 10/17/2024 | Upgraded by | William Blair | Analyst A. Klauber | Market Perform -> Outperform | | High | View details for William Blair rating of The Baldwin Insurance Group (NASDAQ:BWIN) on 10/17/2024 |
APLS Apellis Pharmaceuticals | $27.52
-2.9% | 10/16/2024 | Initiated by | William Blair | Analyst L. Hanbury-Brown | Outperform | | Low | View details for William Blair rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 10/16/2024 |
ESTC Elastic | $106.30
-3.0% | 10/14/2024 | Upgraded by | William Blair | Analyst J. Roberge | Market Perform -> Outperform | | High | View details for William Blair rating of Elastic (NYSE:ESTC) on 10/14/2024 |
WM Waste Management | $227.89
-0.5% | 10/3/2024 | Initiated by | William Blair | Analyst T. Romeo | Outperform | | Low | View details for William Blair rating of Waste Management (NYSE:WM) on 10/3/2024 |
RSG Republic Services | $230.73
-0.1% | 10/3/2024 | Initiated by | William Blair | Analyst T. Romeo | Outperform | | Medium | View details for William Blair rating of Republic Services (NYSE:RSG) on 10/3/2024 |
CWST Casella Waste Systems | $113.99
-1.5% | 10/3/2024 | Initiated by | William Blair | Analyst T. Romeo | Outperform | | Low | View details for William Blair rating of Casella Waste Systems (NASDAQ:CWST) on 10/3/2024 |
TENX Tenax Therapeutics | $6.75
+10.1% | 9/30/2024 | Initiated by | William Blair | Analyst M. Phipps | Outperform | | Medium | View details for William Blair rating of Tenax Therapeutics (NASDAQ:TENX) on 9/30/2024 |
GILT Gilat Satellite Networks | $7.56
-1.7% | 9/26/2024 | Initiated by | William Blair | Analyst L. Dipalma | Outperform | | High | View details for William Blair rating of Gilat Satellite Networks (NASDAQ:GILT) on 9/26/2024 |
SMAR Smartsheet | $56.47
| 9/25/2024 | Reiterated by | William Blair | Analyst J. Roberge | Outperform -> Market Perform | | Low | View details for William Blair rating of Smartsheet (NYSE:SMAR) on 9/25/2024 |
GPN Global Payments | $103.19
-2.3% | 9/25/2024 | Downgraded by | William Blair | Analyst A. Jeffrey | Outperform -> Market Perform | | High | View details for William Blair rating of Global Payments (NYSE:GPN) on 9/25/2024 |
NSP Insperity | $84.94
-1.9% | 9/24/2024 | Downgraded by | William Blair | Analyst A. Nicholas | Outperform -> Market Perform | | High | View details for William Blair rating of Insperity (NYSE:NSP) on 9/24/2024 |
NVDA NVIDIA | $134.35
-4.1% | 9/18/2024 | Initiated by | William Blair | Analyst S. Naji | Outperform | | Medium | View details for William Blair rating of NVIDIA (NASDAQ:NVDA) on 9/18/2024 |
AVGO Broadcom | $218.61
-3.6% | 9/18/2024 | Initiated by | William Blair | Analyst S. Naji | Outperform | | Low | View details for William Blair rating of Broadcom (NASDAQ:AVGO) on 9/18/2024 |
ARM ARM | $144.87
-4.0% | 9/18/2024 | Initiated by | William Blair | Analyst S. Naji | Outperform | | Low | View details for William Blair rating of ARM (NASDAQ:ARM) on 9/18/2024 |
CURV Torrid | $6.02
-3.1% | 9/17/2024 | Upgraded by | William Blair | Analyst D. Carden | Market Perform -> Outperform | | High | View details for William Blair rating of Torrid (NYSE:CURV) on 9/17/2024 |
LZ LegalZoom.com | $8.67
-2.0% | 9/16/2024 | Initiated by | William Blair | Analyst S. Sheldon | Market Perform | | Medium | View details for William Blair rating of LegalZoom.com (NASDAQ:LZ) on 9/16/2024 |
SLP Simulations Plus | $31.77
-0.2% | 9/12/2024 | Reiterated by | William Blair | Analyst M. Smock | Outperform | | Medium | View details for William Blair rating of Simulations Plus (NASDAQ:SLP) on 9/12/2024 |
FTRE Fortrea | $14.88
-4.7% | 9/11/2024 | Reiterated by | William Blair | - | Market Perform | | High | View details for William Blair rating of Fortrea (NASDAQ:FTRE) on 9/11/2024 |
MEDP Medpace | $340.78
-1.2% | 9/11/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Medpace (NASDAQ:MEDP) on 9/11/2024 |
ANRO Alto Neuroscience | $3.21
+2.7% | 9/10/2024 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Alto Neuroscience (NYSE:ANRO) on 9/10/2024 |
CDMO Avid Bioservices | $12.50
+0.1% | 9/10/2024 | Reiterated by | William Blair | - | Market Perform | | High | View details for William Blair rating of Avid Bioservices (NASDAQ:CDMO) on 9/10/2024 |
INCY Incyte | $72.05
+0.9% | 9/9/2024 | Reiterated by | William Blair | - | Outperform | | Medium | View details for William Blair rating of Incyte (NASDAQ:INCY) on 9/9/2024 |
SMWB Similarweb | $9.59
-3.2% | 9/9/2024 | Reiterated by | William Blair | - | Outperform | | High | View details for William Blair rating of Similarweb (NYSE:SMWB) on 9/9/2024 |
ZVRA Zevra Therapeutics | $7.68
-1.9% | 8/30/2024 | Upgraded by | William Blair | Analyst S. Corwin | Strong-Buy | | Low | View details for William Blair rating of Zevra Therapeutics (NASDAQ:ZVRA) on 8/30/2024 |
XENE Xenon Pharmaceuticals | $39.73
+0.9% | 8/30/2024 | Upgraded by | William Blair | Analyst M. Minter | Strong-Buy | | Low | View details for William Blair rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 8/30/2024 |
Grab This Altcoin Before Trump's Crypto Announcement (Ad) Grab This Altcoin Before Trump's Crypto Announcement
Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.
 Click here to check it out now |
VTGN Vistagen Therapeutics | $2.93
+2.1% | 8/30/2024 | Upgraded by | William Blair | Analyst M. Minter | Strong-Buy | | Low | View details for William Blair rating of Vistagen Therapeutics (NASDAQ:VTGN) on 8/30/2024 |
TARS Tarsus Pharmaceuticals | $47.84
-1.8% | 8/30/2024 | Upgraded by | William Blair | Analyst L. Hanbury-Brown | Strong-Buy | | Low | View details for William Blair rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 8/30/2024 |
SRPT Sarepta Therapeutics | $106.28
-2.0% | 8/30/2024 | Upgraded by | William Blair | Analyst S. Corwin | Strong-Buy | | Low | View details for William Blair rating of Sarepta Therapeutics (NASDAQ:SRPT) on 8/30/2024 |
SPRY ARS Pharmaceuticals | $11.24
-4.6% | 8/30/2024 | Upgraded by | William Blair | Analyst L. Hanbury-Brown | Strong-Buy | | Low | View details for William Blair rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 8/30/2024 |
SLDB Solid Biosciences | $5.78
-3.7% | 8/30/2024 | Upgraded by | William Blair | Analyst S. Corwin | Strong-Buy | | Low | View details for William Blair rating of Solid Biosciences (NASDAQ:SLDB) on 8/30/2024 |
OVID Ovid Therapeutics | $0.62
+8.9% | 8/30/2024 | Upgraded by | William Blair | Analyst S. Schram | Strong-Buy | | Low | View details for William Blair rating of Ovid Therapeutics (NASDAQ:OVID) on 8/30/2024 |
LYRA Lyra Therapeutics | $0.21
+4.1% | 8/30/2024 | Upgraded by | William Blair | Analyst L. Hanbury-Brown | Hold | | Low | View details for William Blair rating of Lyra Therapeutics (NASDAQ:LYRA) on 8/30/2024 |
LENZ LENZ Therapeutics | $23.49
-5.8% | 8/30/2024 | Upgraded by | William Blair | Analyst L. Hanbury-Brown | Strong-Buy | | Low | View details for William Blair rating of LENZ Therapeutics (NASDAQ:LENZ) on 8/30/2024 |
KRYS Krystal Biotech | $187.86
+2.9% | 8/30/2024 | Upgraded by | William Blair | Analyst S. Corwin | Strong-Buy | | Low | View details for William Blair rating of Krystal Biotech (NASDAQ:KRYS) on 8/30/2024 |
BMRN BioMarin Pharmaceutical | $68.25
-0.7% | 8/30/2024 | Upgraded by | William Blair | Analyst S. Corwin | Strong-Buy | | Low | View details for William Blair rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 8/30/2024 |
BHVN Biohaven | $36.90
-7.2% | 8/30/2024 | Upgraded by | William Blair | Analyst S. Schram | Strong-Buy | | Low | View details for William Blair rating of Biohaven (NYSE:BHVN) on 8/30/2024 |
AVIR Atea Pharmaceuticals | $3.09
-1.6% | 8/30/2024 | Upgraded by | William Blair | Analyst A. Hsieh | Strong-Buy | | Low | View details for William Blair rating of Atea Pharmaceuticals (NASDAQ:AVIR) on 8/30/2024 |
APLT Applied Therapeutics | $0.53
-6.2% | 8/30/2024 | Upgraded by | William Blair | Analyst L. Hanbury-Brown | Strong-Buy | | Low | View details for William Blair rating of Applied Therapeutics (NASDAQ:APLT) on 8/30/2024 |
ABBV AbbVie | $202.03
+0.6% | 8/30/2024 | Upgraded by | William Blair | Analyst M. Phipps | Strong-Buy | | Low | View details for William Blair rating of AbbVie (NYSE:ABBV) on 8/30/2024 |
FOUR Shift4 Payments | $94.95
-4.0% | 9/4/2024 | Initiated by | William Blair | Analyst A. Jeffrey | Outperform | | Low | View details for William Blair rating of Shift4 Payments (NYSE:FOUR) on 9/4/2024 |
TSLA Tesla | $337.80
-4.7% | 8/29/2024 | Initiated by | William Blair | Analyst J. Dorsheimer | Outperform | | Low | View details for William Blair rating of Tesla (NASDAQ:TSLA) on 8/29/2024 |
SEDG SolarEdge Technologies | $17.62
-3.1% | 8/29/2024 | Initiated by | William Blair | Analyst J. Dorsheimer | Market Perform | | Low | View details for William Blair rating of SolarEdge Technologies (NASDAQ:SEDG) on 8/29/2024 |
GEV GE Vernova | $327.68
-8.9% | 8/29/2024 | Initiated by | William Blair | Analyst J. Dorsheimer | Outperform | | Low | View details for William Blair rating of GE Vernova (NYSE:GEV) on 8/29/2024 |
FSLR First Solar | $155.39
-5.3% | 8/29/2024 | Initiated by | William Blair | Analyst J. Dorsheimer | Market Perform | | Low | View details for William Blair rating of First Solar (NASDAQ:FSLR) on 8/29/2024 |
ENPH Enphase Energy | $64.85
-2.0% | 8/29/2024 | Initiated by | William Blair | Analyst J. Dorsheimer | Market Perform | | Low | View details for William Blair rating of Enphase Energy (NASDAQ:ENPH) on 8/29/2024 |
NCNO nCino | $32.06
-2.4% | 8/28/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of nCino (NASDAQ:NCNO) on 8/28/2024 |
TWFG TWFG | $29.20
-3.9% | 8/21/2024 | Initiated by | William Blair | Analyst A. Klauber | Outperform | | Low | View details for William Blair rating of TWFG (NASDAQ:TWFG) on 8/21/2024 |
SKWD Skyward Specialty Insurance Group | $48.65
-1.8% | 8/19/2024 | Initiated by | William Blair | Analyst A. Klauber | Outperform | | Low | View details for William Blair rating of Skyward Specialty Insurance Group (NASDAQ:SKWD) on 8/19/2024 |
CPAY Corpay | $363.66
-1.4% | 8/8/2024 | Upgraded by | William Blair | Analyst A. Jeffrey | Strong-Buy | | Low | View details for William Blair rating of Corpay (NYSE:CPAY) on 8/8/2024 |
KRRO Korro Bio | $26.29
-8.2% | 8/14/2024 | Initiated by | William Blair | Analyst M. Minter | Outperform | $180.00 | Low | View details for William Blair rating of Korro Bio (NASDAQ:KRRO) on 8/14/2024 |
STIM Neuronetics | $4.13
-14.0% | 8/12/2024 | Reiterated by | William Blair | Analyst M. Kaczor | Outperform -> Market Perform | | Low | View details for William Blair rating of Neuronetics (NASDAQ:STIM) on 8/12/2024 |
RVNC Revance Therapeutics | $3.65
| 8/12/2024 | Reiterated by | William Blair | Analyst T. Lugo | Outperform -> Market Perform | | Low | View details for William Blair rating of Revance Therapeutics (NASDAQ:RVNC) on 8/12/2024 |
FTRE Fortrea | $14.88
-4.7% | 8/12/2024 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Fortrea (NASDAQ:FTRE) on 8/12/2024 |
GPN Global Payments | $103.19
-2.3% | 8/7/2024 | Upgraded by | William Blair | Analyst A. Jeffrey | Strong-Buy | | Low | View details for William Blair rating of Global Payments (NYSE:GPN) on 8/7/2024 |
BRLT Brilliant Earth Group | $1.40
-2.4% | 8/9/2024 | Downgraded by | William Blair | - | Outperform -> Market Perform | | Low | View details for William Blair rating of Brilliant Earth Group (NASDAQ:BRLT) on 8/9/2024 |
BLND Blend Labs | $3.78
-4.2% | 8/9/2024 | Upgraded by | William Blair | Analyst D. Becker | Market Perform -> Outperform | | Low | View details for William Blair rating of Blend Labs (NYSE:BLND) on 8/9/2024 |
TIXT TELUS International (Cda) | $3.36
-6.0% | 8/2/2024 | Downgraded by | William Blair | Analyst M. Nolan | Outperform -> Market Perform | | Low | View details for William Blair rating of TELUS International (Cda) (NYSE:TIXT) on 8/2/2024 |
FTDR Frontdoor | $57.10
-2.3% | 8/2/2024 | Upgraded by | William Blair | Analyst J. Schmitt | Market Perform -> Outperform | | Low | View details for William Blair rating of Frontdoor (NASDAQ:FTDR) on 8/2/2024 |
MA Mastercard | $557.44
-1.0% | 7/31/2024 | Upgraded by | William Blair | Analyst A. Jeffrey | Strong-Buy | | Low | View details for William Blair rating of Mastercard (NYSE:MA) on 7/31/2024 |
APPN Appian | $33.34
-3.7% | 8/1/2024 | Downgraded by | William Blair | Analyst J. Roberge | Outperform -> Market Perform | | Low | View details for William Blair rating of Appian (NASDAQ:APPN) on 8/1/2024 |
XYZ Block | $68.34
-17.7% | 7/31/2024 | Upgraded by | William Blair | Analyst A. Jeffrey | Strong-Buy | | Low | View details for William Blair rating of Block (NYSE:XYZ) on 7/31/2024 |
PYPL PayPal | $74.95
-3.5% | 7/30/2024 | Upgraded by | William Blair | Analyst A. Jeffrey | Hold | | Low | View details for William Blair rating of PayPal (NASDAQ:PYPL) on 7/30/2024 |
APLT Applied Therapeutics | $0.53
-6.2% | 7/31/2024 | Initiated by | William Blair | Analyst T. Lugo | Outperform | | Low | View details for William Blair rating of Applied Therapeutics (NASDAQ:APLT) on 7/31/2024 |
PEGA Pegasystems | $77.89
-4.4% | 7/30/2024 | Upgraded by | William Blair | Analyst J. Roberge | Market Perform -> Outperform | | Low | View details for William Blair rating of Pegasystems (NASDAQ:PEGA) on 7/30/2024 |
MOD Modine Manufacturing | $86.29
-8.3% | 7/29/2024 | Initiated by | William Blair | Analyst B. Drab | Outperform | | Low | View details for William Blair rating of Modine Manufacturing (NYSE:MOD) on 7/29/2024 |
WEX WEX | $150.48
-1.6% | 7/26/2024 | Upgraded by | William Blair | Analyst A. Jeffrey | Strong-Buy | | Low | View details for William Blair rating of WEX (NYSE:WEX) on 7/26/2024 |
FI Fiserv | $232.47
-0.8% | 7/24/2024 | Upgraded by | William Blair | Analyst A. Jeffrey | Strong-Buy | | Low | View details for William Blair rating of Fiserv (NYSE:FI) on 7/24/2024 |
V Visa | $348.27
-0.6% | 7/23/2024 | Upgraded by | William Blair | Analyst A. Jeffrey | Strong-Buy | | Low | View details for William Blair rating of Visa (NYSE:V) on 7/23/2024 |
NARI Inari Medical | $79.97
+0.1% | 7/25/2024 | Initiated by | William Blair | Analyst M. Kaczor | Outperform | | Low | View details for William Blair rating of Inari Medical (NASDAQ:NARI) on 7/25/2024 |
MEDP Medpace | $340.78
-1.2% | 7/23/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Medpace (NASDAQ:MEDP) on 7/23/2024 |
TRUP Trupanion | $32.95
-6.9% | 7/19/2024 | Initiated by | William Blair | Analyst B. Vazquez | Outperform | | Low | View details for William Blair rating of Trupanion (NASDAQ:TRUP) on 7/19/2024 |
AGEN Agenus | $3.32
-3.8% | 7/18/2024 | Downgraded by | William Blair | Analyst M. Phipps | Outperform -> Market Perform | | Low | View details for William Blair rating of Agenus (NASDAQ:AGEN) on 7/18/2024 |
PYPL PayPal | $74.95
-3.5% | 7/18/2024 | Downgraded by | William Blair | Analyst C. Kennedy | Outperform -> Market Perform | | Low | View details for William Blair rating of PayPal (NASDAQ:PYPL) on 7/18/2024 |
XYZ Block | $68.34
-17.7% | 7/18/2024 | Upgraded by | William Blair | Analyst C. Kennedy | Market Perform -> Outperform | | Low | View details for William Blair rating of Block (NYSE:XYZ) on 7/18/2024 |
FIVE Five Below | $85.92
-3.6% | 7/17/2024 | Downgraded by | William Blair | Analyst P. Blee | Outperform -> Market Perform | | Low | View details for William Blair rating of Five Below (NASDAQ:FIVE) on 7/17/2024 |
MSA MSA Safety | $158.30
-0.4% | 7/16/2024 | Upgraded by | William Blair | Analyst R. Sparenblek | Strong-Buy | | Low | View details for William Blair rating of MSA Safety (NYSE:MSA) on 7/16/2024 |
TEM Tempus AI | $68.09
-11.2% | 7/9/2024 | Initiated by | William Blair | Analyst A. Brackmann | Outperform | | Low | View details for William Blair rating of Tempus AI (NASDAQ:TEM) on 7/9/2024 |
BIIB Biogen | $140.64
+2.6% | 7/3/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of Biogen (NASDAQ:BIIB) on 7/3/2024 |
WAY Waystar | $42.21
+3.0% | 7/2/2024 | Initiated by | William Blair | Analyst R. Daniels | Outperform | | Low | View details for William Blair rating of Waystar (NASDAQ:WAY) on 7/2/2024 |
AMED Amedisys | $90.43
-0.7% | 7/1/2024 | Downgraded by | William Blair | Analyst M. Larew | Outperform -> Market Perform | | Low | View details for William Blair rating of Amedisys (NASDAQ:AMED) on 7/1/2024 |
TRV Travelers Companies | $239.90
-0.6% | 6/28/2024 | Reiterated by | William Blair | - | Outperform -> Market Perform | | Low | View details for William Blair rating of Travelers Companies (NYSE:TRV) on 6/28/2024 |
SLP Simulations Plus | $31.77
-0.2% | 6/28/2024 | Initiated by | William Blair | Analyst M. Smock | Outperform | | Low | View details for William Blair rating of Simulations Plus (NASDAQ:SLP) on 6/28/2024 |
CB Chubb | $267.19
-0.1% | 6/28/2024 | Downgraded by | William Blair | - | Market Perform -> Underperform | | Low | View details for William Blair rating of Chubb (NYSE:CB) on 6/28/2024 |
MRNA Moderna | $35.53
+5.3% | 6/27/2024 | Reiterated by | William Blair | - | Market Perform | | Low | View details for William Blair rating of Moderna (NASDAQ:MRNA) on 6/27/2024 |
NCNO nCino | $32.06
-2.4% | 6/26/2024 | Reiterated by | William Blair | - | Outperform | | Low | View details for William Blair rating of nCino (NASDAQ:NCNO) on 6/26/2024 |
